Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NSAIDs, Increased Risk Of Miscarriage Link Suggested In BMJ Study

This article was originally published in The Tan Sheet

Executive Summary

Use of non-steroidal anti-inflammatory drugs during pregnancy does not appear to increase the risk of adverse birth outcomes but may be associated with an increased risk of miscarriage, Danish researchers report.

You may also be interested in...



Prenatal NSAID Use Significantly Underreported - Study

Easy access to nonsteroidal, anti-inflammatory drugs by pregnant women "should be re-evaluated" in light of findings that in utero exposure to aspirin, ibuprofen and naproxen is significantly higher than indicated by maternal history, Michigan researchers say in the March issue of Pediatrics.

Prenatal NSAID Use Significantly Underreported - Study

Easy access to nonsteroidal, anti-inflammatory drugs by pregnant women "should be re-evaluated" in light of findings that in utero exposure to aspirin, ibuprofen and naproxen is significantly higher than indicated by maternal history, Michigan researchers say in the March issue of Pediatrics.

Prenatal NSAID Use Significantly Underreported - Study

Easy access to nonsteroidal, anti-inflammatory drugs by pregnant women "should be re-evaluated" in light of findings that in utero exposure to aspirin, ibuprofen and naproxen is significantly higher than indicated by maternal history, Michigan researchers say in the March issue of Pediatrics.

Topics

UsernamePublicRestriction

Register

PS092178

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel